Startup · $7.8m raised · Healthcare · AI
Developing an AI-powered maternal and foetal health platform ('Oli') that provides early warning for treatable complications in pregnancy and labour.
Programs: ANDHealth (ANDHealth+)
Every investor coverage indicates participated in a round Baymatob raised.
| Investor | Rounds | Invested |
|---|---|---|
| Medical Research Future Fund | Grant | - |
| Alberts | Series A | - |
| Australian Unity | Series A | - |
| Australian Unity's Future of Healthcare Fund | Series A | - |
| Global Bio Fund | Series A | - |
| ANDHealth | Accelerator | - |
Companies Baymatob acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Sarah McDonald | Chief Visionary Officer · Founder | ontargetish.com, Alberts Impact Ventures, Alberts Impact Ventures portfolio (16 Dec 2022), Alberts Impact Ventures portfolio (24 Nov 2022), Alberts Impact Ventures portfolio (23 Mar 2022) |
| Tara Croft | Chief Executive (former) | Startup Daily, Alberts Impact Ventures, Alberts Impact Ventures portfolio (24 Nov 2022), Alberts Impact Ventures portfolio (23 Mar 2022) |
Stories naming Baymatob. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Women's health founders say weak local investment is pushing them offshore; Baymatob, Ovum and BreastScreen leaders describe funding struggles at a Sydney summit, with all-female teams receiving just 2% of 2025 startup capital.
Eight Australian health startups received equity-free grants totaling 18.5 million dollars from the CUREator+ program, supported by government funding and delivered with partners Brandon BioCatalyst and ANDHealth.
Alberts' annual review records its venture arm closing its portfolio at 22 companies, topping up six holdings, co-launching a gender-equity drive, and navigating board changes after Sam Mostyn became Governor-General.
Also Startup Daily
Alberts Impact Ventures introduces its new investment associate in a Q&A covering his prior role at an investment platform, his path into impact investing, and portfolio companies in health and climate.
Roundup of seven Australian startups landing fresh capital and grants: Gaia EnviroTech's $4.3 million deal with RFM, four medtechs sharing $3.25 million via ANDHealth+, Q-CTRL's UK quantum prize, and CarbonHQ's $600,000 pre-seed.
Four Australian medtech companies have received a share of $3.25 million through the ANDHealth+ program, with the money aimed at clinical milestones and global expansion.
Also SmartCompany
Alberts Impact Ventures recaps 2022: six new portfolio companies, five follow-on investments, a led seed round in Abby Health, plus team events, a trade mission and investor recognition.
Alberts announces investment in Baymatob, whose Oli device predicts birth timing and detects hemorrhages, as the first deal in its Equality theme; CEO Tara Croft cites Australian Unity among capital partners in the raise.
Also Alberts Impact Ventures portfolio·Alberts Impact Ventures portfolio